Minimal Clinically Important Difference of Clinical Test of Sensory Interaction on Balance in Ind… (NCT06905730) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Minimal Clinically Important Difference of Clinical Test of Sensory Interaction on Balance in Individuals
Pakistan100 participantsStarted 2025-03-20
Plain-language summary
"Stroke is a major cause of disability worldwide, often leading to balance impairments due to deficits in sensory integration and motor control. These impairments hinder postural stability and functional independence, making balance rehabilitation a critical focus in sub-acute stroke care.
Who can participate
Age range
18 Years – 85 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Type of stroke Participants must have experienced a first unilateral hemispheric supratentorial stroke, which may be either ischemic or hemorrhagic in nature.
* Only individuals who have been clinically diagnosed with a stroke within the past 3 to 6 months will be included.
* Participants must have a Functional Ambulation Classification (FAC) score of 3, indicating independent ambulation with supervision or the use of a walking aid.
* The individual must have sufficient cognitive and communication abilities to understand and follow instructions during assessments.
* The study will include patients in the early subacute phase of stroke recovery, defined as 7 days to 3 months post-onset.
* Participants must have a Montreal Cognitive Assessment (MoCA) score of at least 24, indicating normal cognitive function or only mild cognitive impairment
Exclusion Criteria:
* Individuals with severe cognitive impairments that prevent them from understanding, consenting to, or following simple instructions will be excluded.
* Participants with uncontrolled medical conditions such as cardiovascular disease or uncontrolled diabetes will not be eligible for the study.
* Individuals diagnosed with nerve compression conditions affecting motor or sensory function will be excluded.
* Patients exhibiting significant hemispatial neglect following a stroke will not be included in the study.
* Participants showing signs of unilateral spatial neglect, impacting their ability to …
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.